Comparison of Amitriptyline, Cyclobenzaprine, and Placebo in the Treatment of Fibromyalgia
โ Scribed by Simon Carette; Mary J. Bell; W. John Reynolds; Boulos Haraoui; Glenn A. Mccain; Vivian P. Bykerk; Steven M. Edworthy; Murray Baron; Barry E. Koehler; Adel G. Fam; Nicholas Bellamy; Chantal Guimont
- Publisher
- John Wiley and Sons
- Year
- 1994
- Tongue
- English
- Weight
- 810 KB
- Volume
- 37
- Category
- Article
- ISSN
- 0004-3591
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
We are performing a double-blind trial with inward psychiatric patients. The indication for our psychotropic or psychotherapeutic intervention is mainly severe depression (= major depressive disorders DSM III). For a 3-week trial course trazodone (400 mg daily), amitriptyline (150 mg/die) or placebo
3-Cyano-imipramine (cianopramine) is a potent and selective inhibitor of serotonin uptake into synaptosomes. In a double-blind trial, 60 patients with various types of depression fulfilling the DSM-III criteria of depressive episodes were treated with either cianopramine (n=20, mean daily dose 3.3\_